Back to search

Boston University

Tuning the SUPRA CAR to differentiate high/low Her2 levels

Abstract

dc:description.abstract

On-target, off-tumor toxicity has been a major challenge for chimeric antigen receptor (CAR) T cells to clinically treat solid tumors. This is due to conventional CAR T cells poorly discriminating between high and low tumor associated antigen densities, causing them to attack both cancer and healthy cells. Her2 is a tumor associated antigen where it is minimally expressed in healthy cells and overexpressed in cancer cells of Her2 positive cancer patients. Previous case reports demonstrate that targeting Her2 with conventional ɑ-Her2-CAR could be fatal. To reduce the risk of on-target, off-tumor toxicity, an ultrasensitive CAR T cell platform that highly activates against high antigen density and minimally activates against low antigen density is in need. The Wong lab has developed the split, universal and programmable (SUPRA) CAR system for a safer and more effective CAR. Composed of a universal receptor and an exogenous scFv protein, this split CAR allows safe, effective, and flexible control over T cell activity due to its various tunable components. This thesis aims to demonstrate that the SUPRA CAR can differentiate high and low Her2 densities more than that of a conventional ɑ-Her2-CAR.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Boston University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Shim, Inbo
Advisors dc:contributor.advisor
  • Wong, Wilson W.
  • Nia, Hadi T.

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/45059

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Shim, Inbo. Tuning the SUPRA CAR to differentiate high/low Her2 levels. masters thesis, Boston University, 2022. https://hdl.handle.net/2144/45059